A multi-institutional team led by Weill Cornell Medicine received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases to pursue breakthrough strategies targeting latent HIV reservoirs. This initiative aims to identify and eradicate the root causes of viral persistence, advancing toward a functional cure. The funding underscores federal commitment to transformative HIV research.